Table 4.
Association of fibroblast growth factor 23 with composite outcome after adjustment for mGFR and other variablesa
| Hazard ratio (95% CI) | P value | |
|---|---|---|
| FGF23 adjusted for mGFR | ||
| FGF23 | 1.002 (1.00–1.004) | 0.07 |
| FGF23 adjusted for mGFR and other variablesa | ||
| FGF23 | 1.0002 (0.9999–1.0004) | 0.15 |
| TertileFGF23 (reference = tertile 1) adjusted for mGFR | ||
| FGF23 tertile 2 | 1.15 (0.77–1.72) | 0.50 |
| FGF23 tertile 3 | 1.46 (0.98–2.17) | 0.06 |
| Tertile FGF23 (reference = tertile 1) adjusted for mGFR and other variablesa | ||
| FGF23 tertile 2 | 1.18 (0.77–1.80) | 0.45 |
| FGF23 tertile 3 | 1.33 (0.87–2.04) | 0.19 |
CI, confidence interval; FGF, fibroblast growth factor; mGFR, measured glomerular filtration rate.
a
Age at inclusion, duration of dialysis, first transplantation, living donor, delayed graft function, systolic blood pressure, phosphate, logparathyroid hormone, logcalcitriol.